ad image

Series C Funding

1 / 1
BenchSci
Series C Funding

BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform

BenchSci

PR-M01-22-15Jan 24, 2022
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
Financing

HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders

Nice Insight

PR-M08-19-NI-088Aug 30, 2019
Sirnaomics, Inc.
Series C Financing

Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases

Sirnaomics, Inc.

PR-M04-19-NI-091Apr 30, 2019
1 / 1